ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

XGN vs BDSX // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

Exagen Inc. (NASDAQ) VS. Biodesix Inc. (NASDAQ) • 15-METRIC TALLY: XGN 4 — BDSX 2
■ METRIC PARITY
options-implied-move
—
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XGN VS. BDSX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC XGN BDSX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 58.30% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -6.77% -9.02% +2.25 XGN /fcf-yield <GO>
Operating Margin -21.10% -31.50% +10.40 XGN /operating-margins <GO>
Net Profit Margin -30.00% -39.90% +9.90 XGN /net-margins <GO>
Revenue Growth (YoY) 19.70% 24.10% -4.40 BDSX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 4/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 59.9 50.1 +9.80 XGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $210.8M $260.8M -$50.1M BDSX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR XGN REV BDSX REV XGN GROSS % BDSX GROSS % XGN FCF BDSX FCF
FY 2025 $66.6M $88.5M 58.3% — -$14.3M -$23.5M
FY 2024 $55.6M $71.3M 59.5% — -$13.8M -$51.9M
FY 2023 $52.5M $49.1M — — -$14.5M -$22.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XGN // BETA —
BDSX // BETA —